Stephen Hytha News Today

Why Three Newsletter Writers Like This Energy Saving Strategy Co.

Shares of Alvopetro Energy Ltd. traded 13% higher yesterday after the company reported record Q3/22 sales, raised its quarterly dividend by 50%, and announced plans for a robust NCIB share buyback program.

Shares of turnkey residential solar firm Sunrun Inc. traded 19% higher after the company reported Q3/22 financial results that included a 44% YoY increase in revenue and a 21% gain in its installed customer base.

Altus Power Inc. shares traded 17% higher to a new 52-week high after the industrial, public and community solar firm reported it entered into definitive agreements to acquire 97 megawatts of operating solar assets.

Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher.

Shares of Hycroft Mining Holding Corp. traded 12% higher after the Nevada gold and silver mining firm reported initial drill results from its Hycroft Mine. The company commented that it has encountered multiple zones of continuous higher-grade silver that extend further than prior interpretations.

Japan Gold Corp. shares traded 18% higher after the company reported its development partner and industry major Barrick Gold Corp. has chosen six of its gold projects in Japan to be moved forward to the second evaluation phase for advancement.

Shares of Trillion Energy International Inc. traded 14% higher to a new 52-week high after the company reported it has increased the price it receives for natural gas by 47% to US$31/Mcf.

Forma Therapeutics Holdings Inc. shares traded 51% higher yesterday after the company reported it agreed to be acquired by Denmarks Novo Nordisk A/S in an all-cash deal for $20.00 per share. With the acquisition, Novo Nordisk aims to expand its global presence in the treatment of rare blood disorders and sickle cell disease.

PetroTal Corp. shares traded 11% higher after the company reported Q2/22 financial results highlighting seven consecutive quarters of production growth and reaffirmed its FY/22 guidance for average production of 15,000 bbl/d.